- Advertisement -
Drugmakers are racing to develop new vaccines intended to target the Omicron variant, a coronavirus strain that has mutations that suggest it could evade immunity provided by vaccination or natural infection.
Moderna Chief Medical Officer Dr Paul Burton said in an interview on NBC News that the…
